Skip to content

Effects Of Dexmedetomidine drug group And Fentanyl drug group On Insertion Of i-Gel In Patients planned for Surgery Under full General Anaesthesia

Effects Of Dexmedetomidine And Fentanyl On Insertion Of i-Gel In Patients Undergoing Surgery Under General Anaesthesia- A Randomized Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091540
Enrollment
80
Registered
2025-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine 0.5mcg/kg: Study participants will be randomized into two groups. Intervention group will receive 0.5mcg/kg Dexmedetomidine before induction Control Intervention1: Fenta

Sponsors

A SUDARSHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18-60 years 2. American Society of Anaesthesiologists Physical Status 1 & 2 3. Patients undergoing general anaesthesia for elective surgical procedures

Exclusion criteria

Exclusion criteria: 1.Patients not willing to participate in the study 2. Patients with reduced mouth opening 3. Neck and Facial burns and contracures 4. Modified Mallampati class more than 3 5. Body Mass Index more than 30 6. Thyromental distance less than 6cms 7. Upper and Lower airway obstruction 8. Patients on beta blockers 9. Patients with known allergy to study drugs

Design outcomes

Primary

MeasureTime frame
Objective of this study to assess the effects of dexmedetomidine and fentanyl on the ease of insertion and hemodynamic changes on placement of i-gelTimepoint: Objective of this study to assess the effects of dexmedetomidine and fentanyl on the ease of insertion on placement of i-gel and hemodynamic changes on placement of i-gel after 1minute and 3minutes and 5minutes and 10minutes after the placement of i-gel

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactDr N RATAN SINGH

REGIONAL INSTITUTE OF MEDICAL SCIENCES

drnratansingh@gmail.com9436027270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026